
Neuroscience Daily for 18 September follows 3 stories from r/neuro and r/neuroscience, moving through schizophrenia autoantibodies, germany neurotech, height avoidance. Chapters 00:00:00 — Intro 00:00:13 — Schizophrenia Autoantibodies 00:01:27 — Germany Neurotech 00:02:23 — Height Avoidance 00:03:21 — Closing 1. Schizophrenia Autoantibodies The first story is a bioRxiv study asking how immune activity may relate to schizophrenia. Researchers used a proteome-scale assay to profile autoantibodies in 352 people with schizophrenia and 971 community controls. Source link Reddit discussion 2. Germany Neurotech The second story is a community-made map of neurotechnology companies in Germany and Austria. The post catalogs 59 organizations working across digital therapeutics, EEG, neuromodulation, neuroimaging, rehabilitation, surgical tools, and assistive technology. Source link Reddit discussion 3. Height Avoidance The third story is a bioRxiv preprint on how mice avoid heights. Researchers built a virtual pole-descent task that let mice repeat height-related choices without quickly habituating to the situation. Source link Reddit discussion That's it for today.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Neuroscience Daily for 08 October: Optogenetics Nobel, Dopamine Reward Signals, Social Pain Codes

Neuroscience Daily for 02 October: Attention Signals, Brain Pain, Fruit-Fly Simulation

Neuroscience Daily for 30 September: Brain Aging MRI, Locus Coeruleus Taste, Predictive Learning

Neuroscience Daily for 27 September: Childhood Epilepsy, Riluzole And Glia, Brain As Computer
Free AI-powered recaps of Neuroscience Daily: 5-minute briefing and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.